136 related articles for article (PubMed ID: 21415555)
21. Variation of fasting serum C-peptide level after admission in Japanese patients with type 2 diabetes mellitus.
Tajiri Y; Kimura M; Mimura K; Umeda F
Diabetes Technol Ther; 2009 Sep; 11(9):593-9. PubMed ID: 19764839
[TBL] [Abstract][Full Text] [Related]
22. Combination of disease duration-to-age at diagnosis and hemoglobin A1c-to-serum C-peptide reactivity ratios predicts patient response to glucose-lowering medication in type 2 diabetes: A retrospective cohort study across Japan (JDDM59).
Kanatsuka A; Sato Y; Higashi Y; Goto Y; Kawai K; Maegawa H;
J Diabetes Investig; 2021 Nov; 12(11):1967-1977. PubMed ID: 33837666
[TBL] [Abstract][Full Text] [Related]
23. [Indicators for insulin therapy in late elderly patients with type 2 diabetes mellitus--the relationship between plasma C-peptide on glucagon load test and insulin therapy].
Miyamoto M
Nihon Ronen Igakkai Zasshi; 2009 May; 46(3):244-9. PubMed ID: 19521045
[TBL] [Abstract][Full Text] [Related]
24. Improvement of β-cell function after achievement of optimal glycaemic control via long-term continuous subcutaneous insulin infusion therapy in non-newly diagnosed type 2 diabetic patients with suboptimal glycaemic control.
Choi SB; Lee JH; Lee JH; Kim S; Han SD; Kim IH; Noh YH
Diabetes Metab Res Rev; 2013 Sep; 29(6):473-82. PubMed ID: 23592489
[TBL] [Abstract][Full Text] [Related]
25. Control of postprandial hyperglycemia: optimal use of short-acting insulin secretagogues.
Carroll MF; Izard A; Riboni K; Burge MR; Schade DS
Diabetes Care; 2002 Dec; 25(12):2147-52. PubMed ID: 12453952
[TBL] [Abstract][Full Text] [Related]
26. Body mass index, fasting plasma glucose levels, and C-peptide levels as predictors of the future insulin use in Japanese type 2 diabetic patients.
Goto A; Takaichi M; Kishimoto M; Takahashi Y; Kajio H; Shimbo T; Noda M
Endocr J; 2010; 57(3):237-44. PubMed ID: 20032566
[TBL] [Abstract][Full Text] [Related]
27. Association between the preoperative fasting and postprandial C-peptide AUC with resolution of type 2 diabetes 6 months following bariatric surgery.
Mallipedhi A; Min T; Prior SL; MacIver C; Luzio SD; Dunseath G; Bracken RM; Islam S; Barry JD; Caplin S; Stephens JW
Metabolism; 2015 Nov; 64(11):1556-63. PubMed ID: 26386694
[TBL] [Abstract][Full Text] [Related]
28. Postprandial C-Peptide to Glucose Ratio as a Marker of β Cell Function: Implication for the Management of Type 2 Diabetes.
Saisho Y
Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27196896
[TBL] [Abstract][Full Text] [Related]
29. Pramlintide reduces postprandial glucose excursions when added to insulin lispro in subjects with type 2 diabetes: a dose-timing study.
Maggs DG; Fineman M; Kornstein J; Burrell T; Schwartz S; Wang Y; Ruggles JA; Kolterman OG; Weyer C
Diabetes Metab Res Rev; 2004; 20(1):55-60. PubMed ID: 14737746
[TBL] [Abstract][Full Text] [Related]
30. Increased postprandial GIP and glucagon responses, but unaltered GLP-1 response after intervention with steroid hormone, relative physical inactivity, and high-calorie diet in healthy subjects.
Hansen KB; Vilsbøll T; Bagger JI; Holst JJ; Knop FK
J Clin Endocrinol Metab; 2011 Feb; 96(2):447-53. PubMed ID: 21047927
[TBL] [Abstract][Full Text] [Related]
31. Relation between the serum level of C-peptide and risk factors for coronary heart disease and diabetic microangiopathy in patients with type-2 diabetes mellitus.
Inukai T; Matsutomo R; Tayama K; Aso Y; Takemura Y
Exp Clin Endocrinol Diabetes; 1999; 107(1):40-5. PubMed ID: 10077354
[TBL] [Abstract][Full Text] [Related]
32. Study of genetic prediabetic south Indian subjects. Importance of hyperinsulinemia and beta-cell dysfunction.
Snehalatha C; Ramachandran A; Satyavani K; Latha E; Viswanathan V
Diabetes Care; 1998 Jan; 21(1):76-9. PubMed ID: 9538973
[TBL] [Abstract][Full Text] [Related]
33. Glibenclamide improves postprandial hypertriglyceridaemia in type 2 diabetic patients by reducing chylomicrons but not the very low-density lipoprotein subfraction levels.
Skrapari I; Perrea D; Ioannidis I; Karabina SA; Elisaf M; Tselepis AD; Karagiannacos P; Katsilambros N
Diabet Med; 2001 Oct; 18(10):781-5. PubMed ID: 11678967
[TBL] [Abstract][Full Text] [Related]
34. Postprandial serum C-peptide value is the optimal index to identify patients with non-obese type 2 diabetes who require multiple daily insulin injection: Analysis of C-peptide values before and after short-term intensive insulin therapy.
Fujiwara D; Takahashi K; Suzuki T; Shii M; Nakashima Y; Takekawa S; Yoshida A; Matsuoka T
J Diabetes Investig; 2013 Nov; 4(6):618-25. PubMed ID: 24843717
[TBL] [Abstract][Full Text] [Related]
35. The once-daily human glucagon-like peptide-1 (GLP-1) analog liraglutide improves postprandial glucose levels in type 2 diabetes patients.
Flint A; Kapitza C; Hindsberger C; Zdravkovic M
Adv Ther; 2011 Mar; 28(3):213-26. PubMed ID: 21340616
[TBL] [Abstract][Full Text] [Related]
36. Early liraglutide treatment improves β-cell function in patients with type 2 diabetes: a retrospective cohort study.
Kondo Y; Satoh S; Osada UN; Terauchi Y
Endocr J; 2015; 62(11):971-80. PubMed ID: 26249841
[TBL] [Abstract][Full Text] [Related]
37. Influence of exogenous insulin on C-peptide levels in subjects with type 2 diabetes.
Albareda M; Rigla M; Rodríguez-Espinosa J; Caballero A; Chico A; Cabezas R; Carreras G; Pérez A
Diabetes Res Clin Pract; 2005 Jun; 68(3):202-6. PubMed ID: 15936461
[TBL] [Abstract][Full Text] [Related]
38. Differential effects of body weight, hyperinsulinemia and oral glucose load on serum C-peptide/insulin molar ratio.
Okada N; Kobayashi M; Ohtsuka H; Shigematsu S; Nagasawa Y; Komatsu M; Aizawa T; Yamada T
Horm Metab Res; 1992 Sep; 24(9):429-33. PubMed ID: 1427614
[TBL] [Abstract][Full Text] [Related]
39. Impact of metformin versus the prandial insulin secretagogue, repaglinide, on fasting and postprandial glucose and lipid responses in non-obese patients with type 2 diabetes.
Lund SS; Tarnow L; Frandsen M; Smidt UM; Pedersen O; Parving HH; Vaag AA
Eur J Endocrinol; 2008 Jan; 158(1):35-46. PubMed ID: 18166815
[TBL] [Abstract][Full Text] [Related]
40. Discriminatory ability of simple OGTT-based beta cell function indices for prediction of prediabetes and type 2 diabetes: the CODAM study.
den Biggelaar LJ; Sep SJ; Eussen SJ; Mari A; Ferrannini E; van Greevenbroek MM; van der Kallen CJ; Schalkwijk CG; Stehouwer CD; Dagnelie PC
Diabetologia; 2017 Mar; 60(3):432-441. PubMed ID: 27933333
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
